BRIEF-ARIAD announces FDA full approval and label update for Iclusig (ponatinib)
November 29, 2016 at 10:23 AM EST
* ARIAD announces FDA full approval and label update for Iclusig (ponatinib) based on long-term efficacy and safety data from Phase 2 PACE clinical trial